Autoimmune Diseases by NetCE & Lori Alexander

Author:NetCE & Lori Alexander [Alexander, Lori]
Language: eng
Format: azw3
Tags: Infection Control / Internal Medicine
Publisher: NetCE
Published: 2017-08-03T04:00:00+00:00

Prevention of Comorbidities

The EULAR guidelines recommend a high index of suspicion and prompt evaluation for comorbidities commonly associated with systemic lupus, such as atherosclerosis, hypertension, dyslipidemia, and non-Hodgkin lymphoma [233]. Among patients with systemic lupus, the prevalence of hypertension or dyslipidemia has been reported to range from approximately 11% to 75% [191,253]. Racial disparities exist, with cardiovascular events occurring at a younger age in black women and men [260,261]. Although the increased risk of cardiovascular disease in the systemic lupus population cannot be fully explained by traditional cardiovascular risk factors, experts agree that such risk factors should be evaluated at least annually and that modifiable risk factors should be treated according to established guidelines [233,253].

Hypertension and cardiovascular problems are among the most common comorbidities in individuals with systemic lupus (Table 16) [191]. Hypertension is the leading current comorbidity, and any gastrointestinal problem is the leading lifetime comorbidity. Psychiatric problems and depression are the second and third leading current and lifetime comorbidities [191]. Follow-up care should include patient assessment and preventive strategies for these comorbidities, as well as treatment as appropriate.

Download

Copyright Disclaimer:
This site does not store any files on its server. We only index and link to content provided by other sites. Please contact the content providers to delete copyright contents if any and email us, we'll remove relevant links or contents immediately.